Key result
INTUITY rapid deployment aortic valve replacement shows ~3% 30-day mortality in pooled clinical outcomes.
Why the study?
Rapid deployment valve prostheses were developed to facilitate limited access aortic valve replacement and reduce surgical impact, but a comprehensive overview of current literature was needed.
What are the short-term safety, technical success, and clinical outcomes of the INTUITY or INTUITY Elite rapid deployment aortic valve prosthesis in patients undergoing surgical aortic valve replacement?
Meta-Analysis (n=4,184)
Yes
What are the short-term safety, technical success, and clinical outcomes of the INTUITY or INTUITY Elite rapid deployment aortic valve prosthesis in patients undergoing surgical aortic valve replacement?
Surgical aortic valve replacement with the INTUITY rapid deployment prosthesis achieves high technical success and low 30-day mortality and stroke rates while facilitating minimally invasive approaches, though at the cost of increased permanent pacemaker implantation (7.9%) and paravalvular leak reintervention (3.3%).
Answers are grounded in this paper and cite their sources.
Supports INTUITY rapid-deployment valve consideration in SAVR; extends pooled evidence on short-term outcomes of rapid-deployment prostheses.
OBJECTIVES: Limited access aortic valve replacement is an alternative approach for the treatment of calcified aortic valve disease. To facilitate limited access aortic valve replacement, rapid deployment valve prostheses have been developed aiming to reduce surgical impact. This systematic review gives an overview of current literature regarding the INTUITY or INTUITY Elite rapid deployment biological valve prosthesis. METHODS: Cochrane, Embase and MEDLINE were searched to identify relevant studies. All studies reporting on patients who underwent isolated or combined surgical aortic valve replacement with the INTUITY or INTUITY Elite valve prosthesis were considered eligible. Primary end points were technical success rate, 30-day mortality, cerebrovascular accident, paravalvular leak and permanent pacemaker implantation. Secondary end points included procedural data such as aortic cross-clamping time, cardiopulmonary bypass time and procedural approach. RESULTS: A total of 16 articles fulfilled the inclusion and exclusion criteria and comprised 4.184 patients. Thirty-day mortality was 2.7% (1.9-3.7%), cerebrovascular accident 2.6% (1.4-4.7%), permanent pacemaker implantation 7.9% (6.6-9.5%) and severe postoperative paravalvular leak requiring a reintervention 3.3% (1.7-6.1%). Technical success rate varied between 93.9% and 100%. Conventional median sternotomy was most commonly performed, ranging from 21.7% to 89.6%. Upper hemi-sternotomy was performed more often than anterior right thoracotomy, ranging from 10.4% to 63.3% and 2.2% to 26.1%. The mean transvalvular pressure gradient ranged between 9.0 and 10.3 mmHg at 1 year postoperatively. CONCLUSIONS: This review demonstrates that the technical success rate of the INTUITY or INTUITY Elite rapid deployment valve system is high, also in limited access aortic valve replacement. Mortality and cerebrovascular accident rates are low, but the need for postoperative permanent pacemaker implantation and reintervention rate for paravalvular leakage is increased.
No takes yet. Share an insight, caveat, or question.
Klop et al. (2020) conducted a meta-analysis in Calcified aortic valve disease / severe or symptomatic aortic valve stenosis (n=4,184). INTUITY or INTUITY Elite rapid deployment biological valve prosthesis was evaluated on 30-day mortality (95% CI 1.9-3.7). INTUITY rapid deployment aortic valve replacement yielded a 2.7% 30-day mortality, 2.6% stroke rate, 7.9% permanent pacemaker implantation rate, and 3.3% severe paravalvular leak reintervention rate.
Synapse has enriched 10 related papers. Consider them for comparative context: